Announcement • Jul 10
HCC Healthcare Pte. Ltd. entered into a Business Combination Agreement to acquire RF Acquisition Corp III (NasdaqGM:RFAM) in a reverse merger transaction for approximately $430 million. HCC Healthcare Pte. Ltd. entered into a Business Combination Agreement to acquire RF Acquisition Corp III (NasdaqGM:RFAM) in a reverse merger transaction for approximately $430 million on July 9, 2026. The consideration consists of common equity of RF Acquisition Corp III at an exchange ratio of 1 per common equity of HCC Healthcare Pte. Ltd. As part of consideration, $425.43 million is paid towards common equity of HCC Healthcare Pte. Ltd.
The transaction is subject to execution of employment agreement, approval by regulatory board / committee, approval of merger agreement by target board, approval of offer by acquirer shareholders, approval of offer by acquirer board, approval of offer by target shareholders, obtaining financing, listing of shares and registration statement effectiveness(S-4 / F-4). The deal has been approved by the boards of HCC Healthcare Pte. Ltd. and RF Acquisition Corp III. The expected completion of the transaction in the fourth quarter of 2026.
EarlyBirdCapital, Inc. acted as financial advisor for RF Acquisition Corp III. Michael Blankenship of Winston Taylor LLP acted as legal advisor for RF Acquisition Corp III. James Chen, Joseph Tseng, Robert Matlin and Jonathan Barron of K&L Gates LLP acted as legal advisor for HCC Healthcare Pte. Ltd. PWC Legal acted as legal advisor for HCC Healthcare Pte. Ltd. Bedrock Investment Private Limited acted as strategic consultant for for HCC Healthcare Pte. Ltd.